LumineticsCore® (formerly IDx-DR) is featured in an Ophthalmology Times article highlighting key ophthalmic innovations throughout the decades.
“In DR [diabetic retinopathy], AI algorithms analyze retinal images to accurately identify lesions, which helps clinicians in ophthalmology practice. Systems like IDx-DR are FDA-[cleared] for autonomous detection of referable DR.”